DelveInsight's 'Lupus Nephritis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline lupus ...

GLP-1 receptor agonist use is associated with benefits in a number of different disease and may help treat patients with lupus nephritis.

Combination therapies with immunosuppressive ... to standard cytotoxic therapy lupus nephritis, exerting significant antiproteinuric effects. Therapeutic drug level monitoring and vigilant follow ...

The new guideline also recommends faster tapering to a lower dose of glucocorticoids and a longer duration of ...

Kidney inflammation caused by SLE is referred to as lupus nephritis ... The new drug is thought to have a dual mechanism of action, acting as an immunosuppressant through inhibition of T-cell ...

Two studies presented at the 2024 American College of Rheumatology (ACR) Annual Meeting revealed that GLP-1 receptor agonists ...

Pathology Department, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Bruxelles, Belgium Correspondence to Professor F A Houssiau, Rheumatology Department, Cliniques ...

We are grateful to our colleagues for their interest and thoughtful comments on our Seminar about systemic lupus erythematosus (SLE).1 We appreciate the remarks from Qihe Xu, and Thomas Pabst and ...

The goal of lupus nephritis treatments is to preserve kidney function and reduce morbidity and mortality of chronic kidney ...

The global autoimmune disease therapeutics market is on track for significant expansion, with projections indicating a sharp ...